Filter
2380
Filtered Results: 2380
Text search:
Word
Health
Organization
Featured
Recommendations
232
New Publications
345
Language
Document type
No document type
815
Studies & Reports
595
Guidelines
465
Manuals
209
Strategic & Response Plan
118
Training Material
92
Fact sheets
51
Situation Updates
11
Resource Platforms
9
Infographics
7
Brochures
6
App
1
Online Courses
1
Countries / Regions
Global
156
India
62
Kenya
55
South Africa
46
Russia
37
Western and Central Europe
36
Africa
34
Ethiopia
33
Syria
30
Uganda
29
Ukraine
28
Sierra Leone
25
Liberia
24
Tanzania
22
South–East Asia Region
21
Nigeria
20
Latin America and the Carribbean
20
Middle East and North Africa
20
Nepal
19
Bangladesh
18
Myanmar / Burma
18
Eastern Europe and Central Asia
17
Ghana
16
Malawi
16
Philippines
16
Burkina Faso
14
Mozambique
14
Zambia
14
Eastern Europe
13
Brazil
13
Senegal
12
East and Southern Africa
12
Western Pacific Region
11
Yemen
11
Rwanda
10
Congo, Democratic Republic of
10
Namibia
10
Indonesia
10
Cameroon
9
Cambodia
9
Botswana
9
South Sudan
9
Guinea
8
Asia
8
West and Central Africa
8
Lesotho
7
Zimbabwe
7
Pakistan
7
Benin
6
Germany
6
Colombia
5
Moldova
5
Kazakhstan
4
Kyrgyzstan
4
Sri Lanka
4
Sudan
4
Angola
4
Eswatini/ Swaziland
4
Tajikistan
3
China
3
Laos
3
Peru
3
USA
3
Haiti
3
Guinea-Bissau
3
North America
3
United Kingdom
3
Vietnam
3
Papua New Guinea
3
Romania
3
Palestine
3
Central African Republic
3
North Macedonia
2
Timor Leste/ East Timor
2
Mexico
2
Niger
2
Afghanistan
2
Mongolia
2
Paraguay
2
Gabon
2
Turkmenistan
2
Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Poland
2
Iraq
2
Madagascar
2
Switzerland
1
Thailand
1
El Salvador
1
Serbia
1
Turkey
1
Iran
1
Canada
1
Fiji
1
Estonia
1
Uzbekistan
1
Burundi
1
Malaysia
1
Morocco
1
Qatar
1
Armenia
1
Saudi Arabia
1
Japan
1
Mauritius
1
Tunisia
1
Bolivia
1
Argentina
1
Lebanon
1
Georgia
1
Honduras
1
Mali
1
Chad
1
Ecuador
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
620
Clinical Guidelines
204
Public Health
184
Women & Child Health
175
Key Resources
160
Capacity Building
83
Pharmacy & Technologies
31
Toolboxes
COVID-19
289
Mental Health
198
HIV
142
NTDs
127
Caregiver
120
Disability
117
AMR
97
Planetary Health
96
TB
95
Pharmacy
70
Conflict
68
Rapid Response
62
NCDs
61
Global Health Education
47
Refugee
42
Health Financing Toolbox
41
Malaria
38
Ebola & Marburg
37
Social Ethics
36
Natural Hazards
20
Cholera
15
Specific Hazards
12
Zika
10
Polio
4
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
16-24 February 2020
Pandemics and outbreaks have differential impacts on women and men. From risk of exposure and biological susceptibility to infection to the social and economic implications, individuals’ experiences are likely to vary according to their biological and gender characteristics and...
Guidance statement
Recommendations on contraceptive methods used by
women at high risk of HIV
Nested case-control study of health workers exposed to confirmed COVID-19 patients.
Similar objectives to the cohort study but case-control studies may be cheaper and provide robust evidence to characterize and assess the risk factors for SARS-CoV-2 infection in health workers exposed to COVID-19 p...
In the context of the coronavirus disease (COVID-19) pandemic response, WHO identifies young people as a priority target audience with specific concerns, experiences and behaviours. This policy brief provides relevant insights from behavioural evidence and a set of behavioural considerations for tho...
Several countries have demonstrated that COVID-19 transmission from one person to another can be slowed or stopped. This document has been prepared based on the evidence currently available about Coronavirus disease 2019 (COVID-19) transmission (human-to-human transmission primarily via respiratory...
Prepared by the Independent Panel for Pandemic Preparedness and Response for the WHO Executive Board, January 2021
“The world was not as prepared as it should have been, and it must do better,” concludes a WHO panel reviewing the pandemic response "
The document “Malaria Elimination Programme Review, India 2022”, published by the WHO Country Office for India, provides an in-depth assessment of India’s progress toward malaria elimination. It evaluates the structure, implementation, and effectiveness of national and subnational malaria prog...
The Council was established in late 2020 by Dr Tedros Adhanom
Ghebreyesus (Director-General, WHO) to provide new economic thinking – reassessing how health and wellbeing are valued, produced and distributed across the economy. An all-female group of 10 distinguished economists and area experts, t...
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
WHO recommends artemisinin-based combination therapies for treating uncomplicated malaria, alongside studies to monitor treatment effectiveness. Given the threat of antimalarial resistance, including partial resistance in several African countries, molecular tools are vital for tracking resistance. ...
Meeting report, Kampala, Uganda,
7–8 November 2023
Vector control, alongside case management, remains the most effective approach to controlling and eliminating malaria. Key interventions, such as indoor residual spraying (IRS) and long-lasting insecticidal nets (LLINs), have significantly reduced malaria transmission in many African countries. This...
Circumcision – consultative review of additional information, 12 August 2016
21 September 2016
2nd edition .
This Framework applies to the sharing of H5N1 and other influenza viruses with human pandemic potential and the sharing of benefits. This Framework does not apply to seasonal influenza viruses or other non-influenza pathogens or biological substances that may be contained in clinical ...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
